HRP20110392T1 - Derivati kinolina za liječenje latentne tuberkuloze - Google Patents
Derivati kinolina za liječenje latentne tuberkuloze Download PDFInfo
- Publication number
- HRP20110392T1 HRP20110392T1 HR20110392T HRP20110392T HRP20110392T1 HR P20110392 T1 HRP20110392 T1 HR P20110392T1 HR 20110392 T HR20110392 T HR 20110392T HR P20110392 T HRP20110392 T HR P20110392T HR P20110392 T1 HRP20110392 T1 HR P20110392T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- hydrogen
- use according
- halo
- alkyloxy
- Prior art date
Links
- 206010065048 Latent tuberculosis Diseases 0.000 title claims abstract 3
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title claims abstract 3
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims abstract 40
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 30
- 239000001257 hydrogen Substances 0.000 claims abstract 30
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 26
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 21
- -1 cyano, hydroxy Chemical group 0.000 claims abstract 21
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 18
- 150000001875 compounds Chemical class 0.000 claims abstract 14
- 229930195734 saturated hydrocarbon Natural products 0.000 claims abstract 14
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract 13
- 125000001424 substituent group Chemical group 0.000 claims abstract 11
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract 10
- 125000003386 piperidinyl group Chemical group 0.000 claims abstract 8
- 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract 8
- 239000002253 acid Substances 0.000 claims abstract 7
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract 7
- 150000003839 salts Chemical class 0.000 claims abstract 7
- 125000002757 morpholinyl group Chemical group 0.000 claims abstract 6
- 125000001624 naphthyl group Chemical group 0.000 claims abstract 6
- 125000003373 pyrazinyl group Chemical group 0.000 claims abstract 6
- 150000001204 N-oxides Chemical class 0.000 claims abstract 5
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims abstract 5
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims abstract 5
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 5
- 125000004193 piperazinyl group Chemical group 0.000 claims abstract 5
- 125000004076 pyridyl group Chemical group 0.000 claims abstract 5
- 125000001544 thienyl group Chemical group 0.000 claims abstract 5
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims abstract 5
- 125000001425 triazolyl group Chemical group 0.000 claims abstract 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims abstract 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract 3
- 229910052799 carbon Inorganic materials 0.000 claims abstract 3
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract 3
- 125000002541 furyl group Chemical group 0.000 claims abstract 3
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims abstract 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims abstract 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims abstract 3
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims abstract 3
- 125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 claims abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 2
- 125000004122 cyclic group Chemical group 0.000 claims abstract 2
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims abstract 2
- 125000002632 imidazolidinyl group Chemical group 0.000 claims abstract 2
- 125000001041 indolyl group Chemical group 0.000 claims abstract 2
- 125000001786 isothiazolyl group Chemical group 0.000 claims abstract 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 125000002971 oxazolyl group Chemical group 0.000 claims abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 claims abstract 2
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 2
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims abstract 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims abstract 2
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 2
- 125000000335 thiazolyl group Chemical group 0.000 claims abstract 2
- 125000004306 triazinyl group Chemical group 0.000 claims abstract 2
- 125000005843 halogen group Chemical group 0.000 claims 20
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- XDEHPNQRQKHQQC-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-2-(2,3-difluorophenyl)-4-(dimethylamino)-1-phenylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C(=C(F)C=CC=1)F)C1=CC=CC=C1 XDEHPNQRQKHQQC-UHFFFAOYSA-N 0.000 claims 2
- QUIJNHUBAXPXFS-XLJNKUFUSA-N bedaquiline Chemical compound C1([C@H](C2=CC3=CC(Br)=CC=C3N=C2OC)[C@@](O)(CCN(C)C)C=2C3=CC=CC=C3C=CC=2)=CC=CC=C1 QUIJNHUBAXPXFS-XLJNKUFUSA-N 0.000 claims 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- CLLPSOGUEAXIIW-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-2-(2,5-difluorophenyl)-4-(dimethylamino)-1-phenylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C(=CC=C(F)C=1)F)C1=CC=CC=C1 CLLPSOGUEAXIIW-UHFFFAOYSA-N 0.000 claims 1
- UAUNEMZTBIFYAG-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-2-(3,5-difluorophenyl)-4-(dimethylamino)-1-phenylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C=C(F)C=C(F)C=1)C1=CC=CC=C1 UAUNEMZTBIFYAG-UHFFFAOYSA-N 0.000 claims 1
- VPZIAIQZWHQVKN-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-1,2-diphenylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VPZIAIQZWHQVKN-UHFFFAOYSA-N 0.000 claims 1
- CFPPFXNAPDMERR-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-1-(4-methylphenyl)-2-naphthalen-1-ylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C)C=C1 CFPPFXNAPDMERR-UHFFFAOYSA-N 0.000 claims 1
- HGUAWYGZOVFIAB-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(2-fluorophenyl)-1-phenylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C(=CC=CC=1)F)C1=CC=CC=C1 HGUAWYGZOVFIAB-UHFFFAOYSA-N 0.000 claims 1
- TZNZMTAIOJDNJP-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(3-fluorophenyl)-1-phenylbutan-2-ol Chemical compound COC1=NC2=CC=C(Br)C=C2C=C1C(C(O)(CCN(C)C)C=1C=C(F)C=CC=1)C1=CC=CC=C1 TZNZMTAIOJDNJP-UHFFFAOYSA-N 0.000 claims 1
- GOBOQBZOZDRXCQ-UHFFFAOYSA-N 1-(6-bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol Chemical compound C=1C=CC2=CC=CC=C2C=1C(O)(CCNC)C(C=1C(=NC2=CC=C(Br)C=C2C=1)OC)C1=CC=CC=C1 GOBOQBZOZDRXCQ-UHFFFAOYSA-N 0.000 claims 1
- 125000000815 N-oxide group Chemical group 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000003277 amino group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078529 | 2004-12-24 | ||
| EP05105008 | 2005-06-08 | ||
| PCT/EP2005/056594 WO2006067048A1 (en) | 2004-12-24 | 2005-12-08 | Quinoline derivatives for the treatment of latent tuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110392T1 true HRP20110392T1 (hr) | 2011-06-30 |
Family
ID=35717702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110392T HRP20110392T1 (hr) | 2004-12-24 | 2011-05-24 | Derivati kinolina za liječenje latentne tuberkuloze |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20060142279A1 (de) |
| EP (1) | EP1830850B1 (de) |
| CN (1) | CN103142595B (de) |
| AP (1) | AP2327A (de) |
| AR (1) | AR051790A1 (de) |
| AT (1) | ATE501721T1 (de) |
| AU (1) | AU2005242138B2 (de) |
| BR (1) | BRPI0506400B8 (de) |
| CA (1) | CA2529265C (de) |
| CR (1) | CR9267A (de) |
| CY (1) | CY1112247T1 (de) |
| DE (1) | DE602005026984D1 (de) |
| DK (1) | DK1830850T3 (de) |
| EE (1) | EE05394B1 (de) |
| HK (1) | HK1186125A1 (de) |
| HR (1) | HRP20110392T1 (de) |
| IL (1) | IL184123A (de) |
| LV (1) | LV13469B (de) |
| ME (1) | ME01207B (de) |
| MY (1) | MY145845A (de) |
| NI (1) | NI200700146A (de) |
| NO (1) | NO340376B1 (de) |
| NZ (1) | NZ555460A (de) |
| PA (1) | PA8654801A1 (de) |
| PL (1) | PL1830850T3 (de) |
| PT (1) | PT1830850E (de) |
| RS (1) | RS51730B (de) |
| SI (1) | SI1830850T1 (de) |
| TR (1) | TR200504892A1 (de) |
| TW (1) | TWI404535B (de) |
| WO (1) | WO2006067048A1 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2301544T3 (da) * | 2002-07-25 | 2013-01-02 | Janssen Pharmaceutica Nv | Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer |
| JO3270B1 (ar) * | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
| JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| CA2612614C (en) * | 2005-06-28 | 2017-07-25 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO3271B1 (ar) * | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| US20110059948A1 (en) * | 2008-01-14 | 2011-03-10 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| RU2404971C2 (ru) * | 2008-12-02 | 2010-11-27 | ЗАО "Фарм-Синтез" | Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе |
| WO2010083436A1 (en) | 2009-01-15 | 2010-07-22 | Rutgers, The State University Of New Jersey | Benzo [c] phenanthridines as antimicrobial agents |
| CA2760526A1 (en) | 2009-04-30 | 2010-11-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| CA2810162A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| WO2011163610A2 (en) * | 2010-06-25 | 2011-12-29 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| WO2013106756A2 (en) | 2012-01-13 | 2013-07-18 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| AU2013235038A1 (en) | 2012-03-21 | 2014-10-09 | Malvika Kaul | Antimicrobial agents |
| WO2013160431A1 (en) | 2012-04-27 | 2013-10-31 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| ES2576491T3 (es) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Derivados de quinolina antibacterianos |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| SG11201705944TA (en) | 2015-01-27 | 2017-08-30 | Janssen Pharmaceutica Nv | Dispersible compositions |
| WO2017147316A1 (en) | 2016-02-25 | 2017-08-31 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| CA3016068C (en) | 2016-03-07 | 2024-02-27 | The Global Alliance For Tb Drug Development, Inc. | Antibacterial compounds and uses thereof |
| RU2629369C1 (ru) * | 2016-10-05 | 2017-08-29 | Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" | Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью |
| US10774093B2 (en) | 2017-03-30 | 2020-09-15 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
| EP3651736B1 (de) | 2017-07-14 | 2021-06-23 | Janssen Pharmaceutica NV | Langzeitwirkende formulierungen |
| RU2661151C1 (ru) * | 2017-12-14 | 2018-07-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий |
| JP2022516671A (ja) | 2019-01-09 | 2022-03-01 | ヤンセン ファーマシューティカ エヌ．ベー． | 非結核性抗酸菌症の処置における組合せ |
| EP4178541A1 (de) | 2020-07-09 | 2023-05-17 | JANSSEN Pharmaceutica NV | Formulierungen mit langzeitwirkung |
| AU2021303490A1 (en) | 2020-07-09 | 2023-03-09 | Janssen Pharmaceutica Nv | Long-acting formulations |
| US20230346770A1 (en) | 2020-11-12 | 2023-11-02 | Janssen Pharmaceutica Nv | Combination of bedaquiline, ethambutol and a macrolide in the treatment of nontuberculous mycobacterial diseases |
| WO2023232838A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Pharmaceutica Nv | Bedaquiline for use in the treatment of leprosy |
| WO2024068699A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
| WO2024068693A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| DK2301544T3 (da) * | 2002-07-25 | 2013-01-02 | Janssen Pharmaceutica Nv | Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer |
-
2005
- 2005-12-05 EE EEP200500033A patent/EE05394B1/xx unknown
- 2005-12-06 CA CA2529265A patent/CA2529265C/en active Active
- 2005-12-07 AU AU2005242138A patent/AU2005242138B2/en active Active
- 2005-12-07 PA PA20058654801A patent/PA8654801A1/es unknown
- 2005-12-07 MY MYPI20055732A patent/MY145845A/en unknown
- 2005-12-08 SI SI200531294T patent/SI1830850T1/sl unknown
- 2005-12-08 TR TR2005/04892A patent/TR200504892A1/xx unknown
- 2005-12-08 RS RS20110221A patent/RS51730B/en unknown
- 2005-12-08 TW TW094143290A patent/TWI404535B/zh active
- 2005-12-08 EP EP05815816A patent/EP1830850B1/de active Active
- 2005-12-08 CN CN201210507318.XA patent/CN103142595B/zh active Active
- 2005-12-08 AP AP2007004054A patent/AP2327A/xx active
- 2005-12-08 PL PL05815816T patent/PL1830850T3/pl unknown
- 2005-12-08 NZ NZ555460A patent/NZ555460A/en unknown
- 2005-12-08 PT PT05815816T patent/PT1830850E/pt unknown
- 2005-12-08 US US11/296,992 patent/US20060142279A1/en not_active Abandoned
- 2005-12-08 WO PCT/EP2005/056594 patent/WO2006067048A1/en active Application Filing
- 2005-12-08 DE DE602005026984T patent/DE602005026984D1/de active Active
- 2005-12-08 AT AT05815816T patent/ATE501721T1/de active
- 2005-12-08 ME MEP-2011-92A patent/ME01207B/me unknown
- 2005-12-08 BR BRPI0506400A patent/BRPI0506400B8/pt active IP Right Grant
- 2005-12-08 DK DK05815816.3T patent/DK1830850T3/da active
- 2005-12-09 AR ARP050105140A patent/AR051790A1/es unknown
- 2005-12-09 LV LVP-05-161A patent/LV13469B/lv unknown
-
2007
- 2007-06-05 NI NI200700146A patent/NI200700146A/es unknown
- 2007-06-21 IL IL184123A patent/IL184123A/en active IP Right Grant
- 2007-07-20 CR CR9267A patent/CR9267A/es not_active Application Discontinuation
- 2007-07-23 NO NO20073823A patent/NO340376B1/no unknown
-
2011
- 2011-05-24 HR HR20110392T patent/HRP20110392T1/hr unknown
- 2011-06-15 CY CY20111100563T patent/CY1112247T1/el unknown
-
2013
- 2013-12-09 HK HK13113666.1A patent/HK1186125A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110392T1 (hr) | Derivati kinolina za liječenje latentne tuberkuloze | |
| RS52431B (en) | QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS | |
| CA2566544A1 (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| CA2554049A1 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
| RS53065B (en) | QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS | |
| RS53191B (en) | HINOLINE DERIVATIVES AS ANTI-BACTERIAL AGENTS | |
| RS54794B1 (sr) | Antibakterijski derivati hinolina | |
| HRP20200854T1 (hr) | Novi biciklički inhibitori bromodomene | |
| RS52808B (en) | QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS | |
| CA2553269A1 (en) | Quinoline derivatives and use thereof as mycobacterial inhibitors | |
| HRP20151308T1 (hr) | Antibakterijski derivati kinolina | |
| JP2021501145A5 (de) | ||
| HRP20120762T1 (hr) | Tetrasupstituirani piridazini kao inhibitori hedgehog puta | |
| AR054804A1 (es) | Derivados de quinolina, composicion farmaceutica que los comprende y su uso en combinacion con otros agentes antibacterianos para el tratamiento de infecciones bacterianas | |
| HRP20161704T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| HRP20120910T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| HRP20120912T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| HRP20110540T1 (hr) | Antibakterijski derivati kinolina | |
| AR064147A1 (es) | Derivados de quinolina antibacterianos | |
| JP2006182755A5 (de) | ||
| EA200500802A1 (ru) | Лечение латентного туберкулёза | |
| AR064148A1 (es) | Derivados de quinolina antibacterial |